Results 51 to 60 of about 4,448 (207)

Kidney disease in primary anti-phospholipid antibody syndrome [PDF]

open access: yes, 2017
APS is an autoimmune disease defined by the presence of arterial or venous thrombotic events and/or pregnancy morbidity in patients who test positive for aPL. APS can be isolated (primary APS) or associated with other autoimmune diseases. The kidney is a
Gracia-Tello, B, Isenberg, D
core  

Predictors of mortality in primary antiphospholipid syndrome. A single-centre cohort study. [PDF]

open access: yes, 2016
The vascular mortality of antiphospholipid syndrome (APS) ranges from 1.4 % to 5.5 %, but its predictors are poorly known. It was the study objective to evaluate the impact of baseline lupus anticoagulant assays, IgG anticardiolipin (aCL), plasma ...
Ames, PR   +7 more
core   +1 more source

Treatment of catastrophic antiphospholipid syndrome [PDF]

open access: yesCurrent Opinion in Rheumatology, 2016
Catastrophic antiphospholipid syndrome (CAPS) is a severe manifestation of antiphospholipid syndrome (APS). Although affecting only 1% of patients with APS, the condition is frequently fatal if not recognized and treated early. Here, we will review the current approach to diagnosis and treatment of CAPS.Data from the international 'CAPS registry ...
Nayef M, Kazzaz   +2 more
openaire   +2 more sources

A Diagnostic Challenge: Post‐Transfusion Purpura Unmasked After Multiple Transfusions

open access: yesClinical Case Reports, Volume 14, Issue 1, January 2026.
ABSTRACT Post‐transfusion purpura (PTP) is a rare immune‐mediated post‐transfusion reaction resulting in severe thrombocytopenia. This case presents a 52‐year‐old female with profound thrombocytopenia following multiple transfusions. PTP was not initially suspected due to her history of comorbid anti‐phospholipid antibody syndrome (APS), chemotherapy ...
Jacintha Thomas   +2 more
wiley   +1 more source

A Case Report on Catastrophic Antiphospholipid Syndrome with Cardiomyopathy

open access: yesAnnals of Rheumatology and Autoimmunity, 2023
Catastrophic antiphospholipid syndrome (CAPS) is a life-threatening disease that causes the formation of microthrombi in multiple vascular beds, leading to multiorgan dysfunction.
M. B. Indu   +2 more
doaj   +1 more source

Cutaneous manifestations of antiphospholipid syndrome: a review of the clinical features, diagnosis and management [PDF]

open access: yes, 2013
Antiphospholipid syndrome is a relatively recent systemic autoimmune disorder defined by thrombotic events and/or obstetric complications in the presence of persistent elevated antiphospholipid antibodies.
Caetano, M.   +3 more
core  

Vascular Disease in Systemic Lupus Erythematosus [PDF]

open access: yes, 2012
Vascular disease, either as a direct complication of the disease or developing as an accompanying comorbidity impairs significantly the quality of life of patients with SLE and represents the most frequent cause of death in established lupus.
Athina Pyrpasopoulou   +2 more
core   +1 more source

The Wolf Hidden behind the Clots: Catastrophic Antiphospholipid Antibody Syndrome

open access: yesCase Reports in Medicine, 2018
Catastrophic antiphospholipid syndrome (CAPS) is a rare but highly fatal clinical syndrome that occurs in up to 1% of patients with antiphospholipid syndrome (APS).
Myat Han Soe   +2 more
doaj   +1 more source

Antiphospholipid Syndrome Mimicking Acute Exacerbation of Interstitial Pneumonia: A Case Report and Literature Review

open access: yesRespirology Case Reports, Volume 14, Issue 1, January 2026.
Acute exacerbation of interstitial pneumonia (IP‐AE) is a type of severe respiratory failure that occurs in patients with chronic interstitial pneumonia. However, a few cases of lung involvement caused by antiphospholipid antibody syndrome (APS) appearing similar to IP‐AE have been reported.
Saki Ishii   +11 more
wiley   +1 more source

Successful Management of Relapsed Severe Immune Thrombocytopenia Using Avatrombopag: A Case Report

open access: yesCase Reports in Hematology, Volume 2026, Issue 1, 2026.
Immune thrombocytopenia (ITP) is an acquired autoimmune disorder characterized by increased platelet destruction and impaired platelet production. While thrombopoietin receptor agonists (TPO‐RAs), including romiplostim and eltrombopag, have significantly improved ITP management, some patients remain relapsed to multiple lines of therapy, necessitating ...
Sultan Almutairi   +8 more
wiley   +1 more source

Home - About - Disclaimer - Privacy